Pathogenesis of Bovine Neonatal Pancytopenia
View/ Open
word thesis.zip (19.26Mb)
Bell2014.pdf (10.57Mb)
Date
28/11/2014Item status
Restricted AccessEmbargo end date
31/12/2100Author
Bell, Charlotte Rosie
Metadata
Abstract
Bovine Neonatal Pancytopenia (BNP) is a disease of calves, characterised by
peripheral blood and bone marrow depletion, which emerged in Europe in 2007. A
strong epidemiological association between BNP and the administration of a
particular inactivated Bovine Viral Diarrhoea (BVD) vaccine (Pregsure BVD, Pfizer
Animal Health) to the dams of affected calves has been reported. Early studies
suggested that BNP is mediated by the transfer of alloantibodies in colostrum and
that these alloantibodies recognise major histocompatibility complex (MHC) class I
molecules. This led to the hypothesis that Pregsure contains bovine MHC I
molecules, originating from the MDBK line cell used in vaccine production, and that
this is responsible for the generation of alloantibodies in particular cows injected
with the vaccine.
This project aimed to investigate the mechanisms by which BNP arises and
develops. In particular to gain an understanding of the molecular basis of the
syndrome and how this influences the number of cows and calves affected and the
specificity of the pathology for the haematopoietic system. Haematological analysis
of clinically normal calves born on a BNP-affected farm demonstrated that 15% of
calves had profoundly abnormal haematology and could be described as affected
by subclinical BNP. BNP was reproduced experimentally by feeding pooled
colostrum to neonatal calves, confirming the role of colostrum in mediating the
condition. Detailed analysis of serial haematology and bone marrow pathology from
these calves demonstrated variable alloantibody damages to different
haematopoietic lineages. In vitro cellular assays using a panel of MHC I-defined
bovine leukocyte cell lines and mouse cells individually transfected with the MDBK-MHC
I alleles demonstrated that Pregsure vaccinated cows have significantly higher
titres of functionally active MHC I alloantibodies than BVDV unvaccinated cows or
cows vaccinated with alternative BVDV vaccines. The alloantibody response was
found to be heterogeneous in individual Pregsure vaccinated cows. MHC I
expression levels on peripheral blood and bone marrow cells, assessed by flow
cytometry, was shown to correlate with levels of in vitro and in vivo alloantibody
damage. Overall, the results of this project demonstrate that the pathogenesis of BNP is
mediated by the transfer of MHC I-specific alloantibodies via colostrum that
cause rapid destruction of peripheral blood and bone marrow cells, and which is
dependent on the titre of alloantibody produced by an individual cow, its
specificity for the MHC I alleles present, and density of MHC I expression on the
specific cells.